The pilot project is part of Project Mosaic, an effort to create better disease models of sporadic ALS and spur development of precision drugs.

Despite swimming in different worlds, fish and humans are biologically much closer than one might think. Capitalizing on this ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new therapies for global markets Read more at straitstimes.com. Read more at ...

Animal models are often flawed and offer incomplete representations of human disease. Yet we have long relied on their data to establish the risk/benefit for experimental drugs.

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...

"However, a model like this could conceivably be useful for early drug screening, to study how a drug might cross a barrier similar to the blood-brain barrier, in preparation for animal or human ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

After confirming that the model accurately replicates the human disease, the researchers began testing the effects of various drugs on symptom development.

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

New research reveals that lithium helps protect against neurodegeneration and Alzheimer's disease by preventing toxic amyloid ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.